loadpatents
name:-0.037876129150391
name:-0.031502962112427
name:-0.0043411254882812
Perron; Herve Patent Filings

Perron; Herve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Perron; Herve.The latest application filed is for "anti-herv-k envelope antibody and uses thereof".

Company Profile
3.28.31
  • Perron; Herve - Saint Genis les Ollieres FR
  • PERRON; Herve - Lyon FR
  • Perron; Herve - Lyons FR
  • Perron; Herve - Saint-Genies-les-Ollieres FR
  • Perron; Herve - Paris FR
  • Perron; Herve - Grenoble FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis
Grant 10,981,977 - Perron , et al. April 20, 2
2021-04-20
Antiretroviral drug targeting human endogenous retrovirus
Grant 10,894,820 - Perron , et al. January 19, 2
2021-01-19
Anti-herv-k Envelope Antibody And Uses Thereof
App 20200308258 - PERRON; Herve ;   et al.
2020-10-01
Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
Grant 10,752,675 - Perron , et al. A
2020-08-25
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
Grant 10,723,787 - Perron , et al.
2020-07-28
Anti-herv-k Envelope Antibody And Uses Thereof
App 20190345232 - PERRON; Herve ;   et al.
2019-11-14
Antiretroviral Drug Targeting Human Endogenous Retrovirus
App 20190263895 - Perron; Herve ;   et al.
2019-08-29
Therapeutic use of specific ligand in MSRV associated diseases
Grant 10,059,758 - Bernard , et al. August 28, 2
2018-08-28
Compounds For Treating The Remyelination Blockade In Diseases Associated With The Expression Of Herv-w Envelope Protein
App 20180066040 - PERRON; Herve ;   et al.
2018-03-08
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases
App 20180057569 - BERNARD; Corinne ;   et al.
2018-03-01
Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
Grant 9,840,550 - Perron , et al. December 12, 2
2017-12-12
Therapeutic use of specific ligand in MSRV associated diseases
Grant 9,815,888 - Bernard , et al. November 14, 2
2017-11-14
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases
App 20170107274 - BERNARD; Corinne ;   et al.
2017-04-20
Antiretroviral Drug Targeting Human Endogenous Retrovirus
App 20170101461 - Perron; Herve ;   et al.
2017-04-13
Therapeutic use of specific ligand in MSRV associated diseases
Grant 9,550,824 - Bernard , et al. January 24, 2
2017-01-24
Compounds For Treating The Remyelination Blockade In Diseases Associated With The Expression Of Herv-w Envelope Protein
App 20150218256 - Perron; Herve ;   et al.
2015-08-06
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases
App 20140220026 - BERNARD; Corinne ;   et al.
2014-08-07
Therapeutic use of specific ligand in MSRV associated diseases
Grant 8,715,656 - Bernard , et al. May 6, 2
2014-05-06
Endogenetic Retroviral Sequences, Associated With Autoimmune Diseases Or With Pregnancy Disorders
App 20130115602 - BESEME; Frederic ;   et al.
2013-05-09
Endogenetic Retroviral Sequences, Associated With Autoimmune Diseases Or With Pregnancy Disorders
App 20120190569 - BESEME; Frederic ;   et al.
2012-07-26
Method for detecting aggregate-forming circulating protein forms using an agent for aggregating said forms and an agent for capturing formed aggregates
Grant 8,158,441 - Cecillon , et al. April 17, 2
2012-04-17
Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region
Grant 8,088,910 - Paranhos-Baccala , et al. January 3, 2
2012-01-03
Therapeutic Use Of Specific Ligand In Msrv Associated Diseases
App 20110243962 - Bernard; Corinne ;   et al.
2011-10-06
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
Grant 7,932,350 - Perron , et al. April 26, 2
2011-04-26
Retroviral Nucleic Material And Nucleotide Fragments, In Particular Associated With Multiple Sclerosis And/or Rheumatoid Arthritis, For Diagnostic, Prophylactic And Therapeutic Uses
App 20100285448 - PARANHOS-BACCALA; Glaucia ;   et al.
2010-11-11
Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
Grant 7,771,927 - Paranhos-Baccala , et al. August 10, 2
2010-08-10
Method of isolating cytotoxic heterocomplex associated with multiple sclerosis
Grant 7,700,294 - Perron , et al. April 20, 2
2010-04-20
Process for detecting PrP.sup.SC using an antibiotic from the family of aminoglycosides
Grant 7,695,918 - Moussa , et al. April 13, 2
2010-04-13
Pharmaceutical Composition Containing Antibodies Directed Against The Herv-w Envelope
App 20100074894 - Perron; Herve
2010-03-25
Method for Detecting Aggregate-Forming Circulating Protein Forms Using an Agent for Aggregating Said Forms and an Agent for Capturing Formed Aggregates
App 20100062540 - Cecillon; Sebastien ;   et al.
2010-03-11
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
Grant 7,674,888 - Perron , et al. March 9, 2
2010-03-09
Composition for treating pathology associated with MSRV/HERV-W
Grant 7,666,420 - Marche , et al. February 23, 2
2010-02-23
Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
App 20090286269 - Benscik-Reynier; Anna ;   et al.
2009-11-19
Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
Grant 7,566,530 - Benscik-Reynier , et al. July 28, 2
2009-07-28
Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
Grant 7,510,843 - Roecklin , et al. March 31, 2
2009-03-31
Method For Detecting Prp Using at Least One Positive Charge and/or at Least One Glycosidic Bond and a Ligand Other Than a Protein Ligand
App 20080176256 - Benscik-Reynier; Anna ;   et al.
2008-07-24
LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus
Grant 7,381,817 - Paranhos-Baccala , et al. June 3, 2
2008-06-03
Composition For Treating Pathology Associated With Msrv/Herv-W
App 20080038279 - Marche; Patrice ;   et al.
2008-02-14
Process for detecting PrP using a macrocyclic adjuvant ligand
App 20070154885 - Moussa; Aly ;   et al.
2007-07-05
Viral Material And Nucleotide Fragments Associated With Multiple Sclerosis, For Diagnostic, Prophylactic And Therapeutic Purposes
App 20070117189 - PERRON; Herve ;   et al.
2007-05-24
Process for detecting PrP using a macrocyclic adjuvant ligand
Grant 7,217,530 - Moussa , et al. May 15, 2
2007-05-15
Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor
App 20070065881 - Perron; Herve ;   et al.
2007-03-22
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
App 20070031452 - Perron; Herve ;   et al.
2007-02-08
Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
App 20060223121 - Roecklin; Dominique ;   et al.
2006-10-05
Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
Grant 7,081,345 - Roecklin , et al. July 25, 2
2006-07-25
Detecting superantigen activity in a biological sample
App 20060088820 - Perron; Herve ;   et al.
2006-04-27
Process for detecting PrP using a macrocyclic adjuvant ligand
App 20060019311 - Moussa; Aly ;   et al.
2006-01-26
Process for detecting PRPsc using an antibiotic from the family of aminoglycosides
App 20060014215 - Moussa; Aly ;   et al.
2006-01-19
Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
App 20040176314 - Beseme, Frederic ;   et al.
2004-09-09
The LTR region of MSRV-1 and the proteins it encodes and probes and methods for detecting MSRV-1 retrovirus
App 20040043381 - Paranhos-Baccala, Glaucia ;   et al.
2004-03-04
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
App 20030198647 - Perron, Herve ;   et al.
2003-10-23
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
App 20030186391 - Perron, Herve ;   et al.
2003-10-02
Isolated Nucleotide Sequences Associated With Multiple Sclerosis Or Rheumatoid Arthritis And A Process Of Detecting
App 20030039664 - PERRON, HERVE ;   et al.
2003-02-27
Cell lines and viral isolates associated with multiple sclerosis
Grant 6,342,383 - Perron , et al. January 29, 2
2002-01-29
Method for detecting and/or quantifying a gliotoxic factor
Grant 6,270,953 - Malcus-Vocanson , et al. August 7, 2
2001-08-07
Isolated nucleotide sequences associated with Multiple sclerosis
Grant 6,001,987 - Perron , et al. December 14, 1
1999-12-14
Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus
Grant 5,925,555 - Perron , et al. July 20, 1
1999-07-20
Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
Grant 5,800,980 - Perron , et al. September 1, 1
1998-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed